Vanna Sanna
- Biomedical Engineering top 5%
- Molecular Biology top 10%
- Biomaterials top 1%
- Pharmaceutical Science top 0.5%
- Materials Chemistry top 10%
- Co-authors
- Mario SechiNicolino PalaImtiaz A. SiddiquiAlberto MarianiElisabetta GaviniPaolo GiunchediHasan MukhtarEfrem Curcio
- Topics
- Nanoparticle-Based Drug Delivery (14 papers)Advancements in Transdermal Drug Delivery (10 papers)Advanced Drug Delivery Systems (9 papers)
- Journals
- Advanced MaterialsSHILAP Revista de lepidopterologíaCancer Research
- Partner nations
- ItalyUnited StatesBelgium
In The Last Decade
Vanna Sanna
69 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Biomedical Engineering 874
- Molecular Biology 872
- Biomaterials 832
- Pharmaceutical Science 722
- Materials Chemistry 572
Countries citing papers authored by Vanna Sanna
This map shows the geographic impact of Vanna Sanna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanna Sanna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanna Sanna more than expected).
Fields of papers citing papers by Vanna Sanna
This network shows the impact of papers produced by Vanna Sanna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanna Sanna. The network helps show where Vanna Sanna may publish in the future.
Co-authorship network of co-authors of Vanna Sanna
This figure shows the co-authorship network connecting the top 25 collaborators of Vanna Sanna. A scholar is included among the top collaborators of Vanna Sanna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanna Sanna. Vanna Sanna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 44 | |
| 3 | 54 | |
| 4 | 118 | |
| 5 | 5 | |
| 6 | 90 | |
| 7 | 60 | |
| 8 | 40 | |
| 9 | 52 | |
| 10 | 56 | |
| 11 | Prostate specific membrane antigen (PSMA) targeting nano-EGCG for prostate cancer prevention and treatment | 1 |
| 12 | 30 | |
| 13 | 72 | |
| 14 | 59 | |
| 15 | 42 | |
| 16 | 129 | |
| 17 | 32 | |
| 18 | 75 | |
| 19 | 31 | |
| 20 | 134 |
About Vanna Sanna
Vanna Sanna is a scholar working on Pharmaceutical Science, Biomaterials and Dermatology, having authored 69 papers that have together received 3.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (14 papers), Advancements in Transdermal Drug Delivery (10 papers) and Advanced Drug Delivery Systems (9 papers). The work is most often cited by research in Pharmaceutical Science (722 citations), Biomaterials (832 citations) and Molecular Medicine (250 citations). Vanna Sanna has collaborated with scholars based in Italy, United States and Belgium. Frequent co-authors include Mario Sechi, Nicolino Pala, Imtiaz A. Siddiqui, Alberto Mariani, Elisabetta Gavini, Paolo Giunchedi, Hasan Mukhtar, Efrem Curcio, Gianluca Di Profio and A. Cupolillo. Their work appears in journals such as Advanced Materials, SHILAP Revista de lepidopterología and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.